Related Experiment Video
Updated: Mar 6, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival
Theresa M Thole1,2,3, Marco Lodrini1,3, Johannes Fabian3
1Department of Pediatric Hematology, Oncology and SCT, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, Berlin 13353, Germany.
Abstract:
The number of long-term survivors of high-risk neuroblastoma remains discouraging, with 10-year survival as low as 20%, despite decades of considerable international efforts to improve outcome. Major obstacles remain and include managing resistance to induction therapy, which causes tumor progression and early death in high-risk patients, and managing chemotherapy-resistant relapses, which can occur years after the initial diagnosis. Identifying and validating novel therapeutic targets is essential to improve treatment. Delineating and deciphering specific functions of single histone deacetylases in neuroblastoma may support development of targeted acetylome-modifying therapeutics for patients with molecularly defined high-risk neuroblastoma profiles. We show here that HDAC11 depletion in MYCN-driven neuroblastoma cell lines strongly induces cell death, mostly mediated by apoptotic programs. Genes necessary for mitotic cell cycle progression and cell division were most prominently enriched in at least two of three time points in whole-genome expression data combined from two cell systems, and all nine genes in these functional categories were strongly repressed, including CENPA, KIF14, KIF23 and RACGAP1. Enforced expression of one selected candidate, RACGAP1, partially rescued the induction of apoptosis caused by HDAC11 depletion. High-level expression of all nine genes in primary neuroblastomas significantly correlated with unfavorable overall and event-free survival in patients, suggesting a role in mediating the more aggressive biological and clinical phenotype of these tumors. Our study identified a group of cell cycle-promoting genes regulated by HDAC11, being both predictors of unfavorable patient outcome and essential for tumor cell viability. The data indicate a significant role of HDAC11 for mitotic cell cycle progression and survival of MYCN-amplified neuroblastoma cells, and suggests that HDAC11 could be a valuable drug target.
Insights
Histone deacetylase 11 (HDAC11) is crucial for neuroblastoma cell survival and proliferation. Inhibiting HDAC11 triggers cell death and may offer a new therapeutic strategy for high-risk neuroblastoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- High-risk neuroblastoma has poor survival rates (20% at 10 years) due to treatment resistance and relapse.
- Novel therapeutic targets are urgently needed to improve outcomes for these patients.
- Understanding the role of specific histone deacetylases (HDACs) may lead to targeted therapies.
Purpose of the Study:
- To investigate the function of HDAC11 in MYCN-driven neuroblastoma.
- To identify potential therapeutic targets for high-risk neuroblastoma.
Main Methods:
- Depletion of HDAC11 in MYCN-driven neuroblastoma cell lines.
- Whole-genome expression analysis to identify regulated genes.
- Functional rescue experiments with candidate genes.
- Correlation analysis with patient survival data.
Main Results:
- HDAC11 depletion induced significant cell death, primarily through apoptosis.
- Genes promoting mitotic cell cycle progression (e.g., CENPA, KIF14) were repressed upon HDAC11 depletion.
- High expression of these cell cycle genes correlated with poor patient survival.
- RACGAP1, a cell cycle gene, partially rescued apoptosis when its expression was restored.
Conclusions:
- HDAC11 plays a critical role in the survival and mitotic progression of MYCN-amplified neuroblastoma cells.
- HDAC11 regulates a set of cell cycle genes that are both essential for tumor cell viability and predictive of poor patient outcomes.
- HDAC11 represents a promising therapeutic target for high-risk neuroblastoma.
More Related Videos
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
05:10Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Related Concept Videos
Abnormal Proliferation
Inhibition of Cdk Activity
Mitogens and the Cell Cycle
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
DNA Damage can Stall the Cell Cycle
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...